Clinical Trial Update: Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia [Phase 3]

View source ↗

Summary

Phase 3 trial update on initial treatment with bevacizumab for neovascularization due to high myopia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Subfoveal Juxtafoveal Neovascularization in High Myopia

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia | Phase 3 | Status: COMPLETED